Actemra actpen 162 MG/0.9 ML 0.9ML
Ended Awarded Last action
- Contract number
- SPE2DR26FN0U3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,682
Award facts
- Contract value 100% obligated
- $12,681.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,681.85 to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 21, 2026, for the supply of Actemra ActPen 162 mg/0.9 ml auto-injector pens. This firm fixed-price delivery order, with an ultimate completion date of January 22, 2026, represents a single-transaction procurement under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively made with no set-aside designation, reflecting the contractor's capability to meet federal pharmaceutical procurement requirements through open competition. The product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania.
This delivery order falls under AmerisourceBergen's substantial $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. Actemra (tocilizumab) is a biologic immunosuppressant used in treating rheumatoid arthritis and other inflammatory conditions, representing the type of specialty pharmaceutical products the company supplies across multiple therapeutic domains to Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FN0U3?
SPE2DR26FN0U3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FN0U3 worth?
The government has obligated $12,682 on SPE2DR26FN0U3.
Is contract SPE2DR26FN0U3 an order under another contract?
Yes. SPE2DR26FN0U3 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FN0U3 competed?
The extent of competition for SPE2DR26FN0U3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award